EPIZYME - Key Persons
Job Titles:
- Executive Vice President, Technical Operations
Aidan Murphy, Ph.D. was appointed Executive Vice President, Technical Operations in January 2018.
Aidan has more than 25 years' experience in the pharmaceutical and biotechnology industry, and since joining Ipsen in 2006 has held several manufacturing leadership roles across the globe.
Prior to his current role, Aidan was Senior Vice President, Biologics Development and Manufacturing, and has also led Ipsen's manufacturing sites in Tianjin (China), Dublin (Ireland), and Wrexham (UK) and occupied global roles as SVP CMC (Chemistry, Manufacturing, and Controls) Development & Engineering and Head of Specialty Care Manufacturing. He holds a Ph.D. in organic chemistry from Trinity College, Dublin.
Job Titles:
- Senior Director
- VP, Business Ethics North America
Ali brings more than 16 years of combined experience in both commercial and business ethics in the pharmaceutical and biotech industry. Since being named to her current role in 2022, Ali is a strategic advisor and partner to the North American Leadership Team, promoting a culture of ethics and business accountability.
Ali joined Ipsen in June 2020 as Senior Director, US Business Ethics and most recently led the business ethics team responsible for the EU5, LATAM, and Global Products and Portfolio Strategy. Prior to joining Ipsen, Ali held various positions of increasing responsibility in Ethics and Compliance at companies such as Amryt Pharma, PLC, Aegerion Pharmaceuticals, INC, and Eli Lilly & Company.
Ali's deep knowledge of ethics and compliance and broad commercial experience helps her to set her business partners up for success. She holds a BS in Biology with a minor in Chemistry from Florida State University.
Job Titles:
- Chairman
- Member of the Compensation Committee
- Member of Innovation and Development Committee
- Vice - Chairman of the Board of Directors )
Job Titles:
- Executive Vice President
- Group Chief Financial Officer
Aymeric Le Chatelier was appointed Executive Vice President, Group Chief Financial Officer in November 2014.
Aymeric, a graduate from HEC Business School, started his career at Arthur Andersen. He successively executed several roles in finance in France and the United States at Veolia. He then joined Arjowiggins, a leading manufacturer of creative and technical paper, as Group Chief Financial Officer. He was subsequently appointed Financial Director of Enedis and member of the Management Board.
Aymeric served as interim Chief Executive Officer of the Group from 1 January 2020 until David Loew was appointed Chief Executive Officer in July 2020.
Job Titles:
- Executive Vice President, Head of Global Product and Portfolio Strategy
Bartosz (Bartek) Bednarz, DDS joined Ipsen in 2017.
He currently serves as Executive Vice President, Head of Global Product and Portfolio Strategy at Ipsen, which covers Global Franchises, Global Value and Access and Global Strategic Business Excellence.
Before assuming his current role, Bartosz successfully led Ipsen's oncology franchise. Prior to that, he held global leadership roles at AstraZeneca and Novartis. At AstraZeneca, where Bartosz spent seven years, he started as Country President and later led new launches in oncology as well as Oncology Commercial Operations at a global level while based in Cambridge (UK). At Novartis, Bartosz held various commercial leadership roles at local, regional and international levels around the world, including Poland, Spain, Switzerland and Canada. He has worked across multiple therapeutic areas and is very passionate about Ipsen's focus in oncology, rare disease and neuroscience.
Bartosz Bednarz holds a Doctor of Dental Medicine, and he obtained his diploma with honors at the Medical University of Pomerania in Poland.
Job Titles:
- Chairman
- Member of the Nomination Committee
- Independent Member
Job Titles:
- Marketing and Sales Leader
- Senior Business Unit Director
- Vice President, Franchise Head, Neuroscience Business Unit
Chris Watters is a proven marketing and sales leader with a track record of developing and executing strategies to exceed revenue and profit targets in both global organizations and start-ups over the past 20 years. In his role as Vice President, Neuroscience Business Unit, Chris is responsible for driving the strategy and execution of all activities related to the company's neuroscience product portfolio as well as for developing and implementing long-term strategic growth initiatives for the franchise.
Chris joined Ipsen Canada in August of 2019 as Senior Business Unit Director, Rare Disease and Neuroscience where he successfully led the building of the new Rare Disease business unit for Canada and transformed our existing Neuroscience business unit to deliver accelerated growth. In 2020, he relocated to the U.S. as Senior Director, Neuroscience Marketing.
Prior to joining Ipsen, Chris worked at Cipher Biotech where he was Vice President, Corporate Development. While at Cipher he was instrumental in transforming the organization by driving strategic restructuring of the business, establishing marketing, market access, and business development capabilities. Chris, a pharmacist by training, spent most of his career at GlaxoSmithKline, most recently as Vice President of Sales. He worked in progressively more senior sales and marketing roles at both GSK and Biovail, including Vice President of Marketing, and National Director of Sales. Chris earned both his Bachelor of Pharmacy and Executive MBA from the University of Toronto.
Job Titles:
- Senior Vice President, Franchise Head, Oncology Business Unit
David Daya was appointed Senior Vice President, Franchise Head, Oncology Business Unit in October 2021. In this role, David leads Ipsen's growing oncology franchise in the U.S., providing vision, leadership and oversight for the commercial team. He is responsible for the overall development and implementation of long-term strategic growth initiatives for the oncology franchise.
David joined Ipsen in 2019 as Vice President and General Manager of the Nordics and Baltics, based in Sweden, where under his leadership the business grew more than 10% in 2020 and market share grew across all specialty brands. Prior to joining Ipsen, David spent more than 17 years at Eli Lilly. In his last role at Lilly, he served as the Oncology Therapeutic Area Head for International Markets. He also worked across various international commercial roles, living and working in Canada and Belgium.
David is from Beirut, Lebanon and holds a dual degree in Biology and Chemistry from the Lebanese American University and a Business Management degree from McGill University.
Job Titles:
- Chief Executive Officer
- 1 Independent Member
David Loew was appointed as Chief Executive Officer of Ipsen on July 1, 2020.
David brings nearly 30 years of leadership and experience across a range of therapeutic areas, including oncology, CNS and cardio-metabolism, as well as consumer healthcare. He has worked in the U.S., European and international markets. He began his career at Coopers & Lybrand and Hewlett Packard in 1990 before joining Roche in 1992. Over the following two decades, David held a variety of positions, including Global Oncology Head, Global Chief Marketing Officer & Head of Global Product Strategy and Region Head, Eastern Europe, Middle East and Africa for the Pharma Division of Roche. He joined Sanofi in July 2013 as Senior Vice President, Commercial Operations Europe, where he was responsible for the prescription, consumer healthcare and generics business across the EU region. In 2016, David was appointed CEO of Sanofi Pasteur Vaccines.
David currently serves on the Boards of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), and G5 Santé, the federation of French pharmaceutical companies.
David earned his BA in Business Administration and MBA from the University of St. Gallen, Switzerland.
Job Titles:
- Director
- Member of Innovation and Development Committee
Job Titles:
- Vice President, Regulatory Affairs, Quality & Safety, North America
Drew Sansone joined Ipsen in May 2016 and brings over twenty-five years of regulatory affairs experience across multiple therapeutic areas at both large multi-national pharmaceutical companies and small to mid-sized biotech companies. He has diverse expertise in all aspects of regulatory affairs and proven successes with multiple international product registrations, first-in-class novel combination therapies, leading submission and approval processes for multiple Global New Chemical Entity submissions, and with maintaining an excellent repertoire with United States and worldwide health authorities. Before joining Ipsen, Drew was most recently at Abbvie where he was responsible for the Hepatitis C franchise. Additionally, he's held roles at AstraZeneca, Tengion and Vicuron Pharmaceuticals. Drew holds a Masters in Regulatory Affairs and Quality Assurance from Temple University and a Bachelor of Arts in Psychology and Business Administration from Siena College.
Job Titles:
- General Manager, Ipsen Canada
Job Titles:
- Vice President and Franchise Head, Rare Diseases North America
Job Titles:
- Vice President, Finance, North America
Job Titles:
- Executive Vice President, General Counsel and Chief Business Ethics Officer
François Garnier was appointed Executive Vice President, General Counsel in December 2014.
François began his career in 1989 at Servier S.A. as International Contracts Manager and remained with the company until September 1995. He then moved to Rhône Poulenc Rorer S.A. to take up the position of Counsel for Corporate Transactions. In 1996 he moved to the United States as Associate Counsel, before being appointed Chief Counsel for France in 1999. François continued his career as Chief Counsel at Aventis Animal Nutrition until 2001, when he joined the Pharmacia Group as Chief Counsel for Europe.
François joined Pfizer France in 2003, as Vice-President, General Counsel before moving on to become Chief Counsel for Pfizer's operations in Europe from 2009 to 2014. He was International Chief Counsel (ex-US) for Pfizer Inc. from January 2014.
Job Titles:
- Executive Vice President, Communications and Public Affairs
Gwenan White joined Ipsen on March 1, 2021 as Executive Vice President, Communications and Public Affairs.
In her role, Gwenan is responsible for designing, implementing and managing the communications and public affairs strategy for Ipsen. She brings 30 years of experience in pharmaceuticals at global, regional and country roles. Before joining Ipsen, Gwenan was the Global Head of Pharma Communications and Patient Advocacy at Novartis and member of the Pharma Executive Committee. Over the course of her career, she has held a variety of leadership roles of in public affairs, corporate, science and product communications, patient advocacy and marketing at AbbVie, GSK and Schering-Plough.
Gwenan holds a degree in Biochemistry from the University of Liverpool.
Job Titles:
- Executive Vice President, Head of Research and Development
Howard Mayer, M.D. joined Ipsen in December 2019 as Executive Vice President, Head of Research and Development.
Howard joined Ipsen from Shire, where he was Chief Medical Officer, responsible for the hematology, immunology, oncology, genetic diseases, GI/metabolic, neuroscience and ophthalmology therapeutic areas.
Previously, he served as Chief Medical Officer at EMD Serono, a division of Merck KGaA. Prior to that, he held a variety of global roles at Pfizer, including Head, Clinical Development and Medical Affairs for Virology/Infectious Diseases. Prior to joining Pfizer, he served as Director of Clinical Research at Bristol-Myers Squibb.
Howard obtained his B.A. from the University of Pennsylvania and his M.D. from Albert Einstein College of Medicine, which was followed by an internship and residency at Mount Sinai Hospital and an Infectious Diseases fellowship at Harvard Medical School. He currently serves on the board of directors for Genocea Biosciences and Entasis Therapeutics, and on the board of Autism Speaks in New England. He was honored by PharmaVoice as one of the 100 Most Inspiring People in the Life Sciences Industry in both 2011 and 2017.
Job Titles:
- Senior Vice President and North America General Counsel, Legal Affairs
Jennifer Benenson brings more than 25 years of experience as counsel in the pharmaceutical industry to her role as Senior Vice President and North American General Counsel. She is responsible for managing the delivery of legal services to Ipsen business units in North America and advising the leadership team on strategic matters.
Prior to joining Ipsen in 2011, Jennifer served as Vice President and General Counsel at Daiichi Sankyo, Inc., for 10 years; Vice President of Legal Affairs at Dr. Reddy's Laboratories, Vice President, Legal, at Medco Health Solutions Inc., and entered the industry as a staff attorney at Ciba-Geigy (now, Novartis).
Jennifer earned her undergraduate degree in Political Science from Brown University, including a year of study at the London School of Economics and Political Science, and her JD from Columbia University School of Law.
Job Titles:
- Chairman
- Member of the Audit Committee
- Member of the Compensation Committee
Job Titles:
- Vice President, Value & Access
Kimberly Baldwin has 20 years of diverse experience in healthcare sales, marketing and market access across multiple therapeutic areas. In her role as Vice President, Value and Access, Kim is responsible for leading the Strategic Pricing, Account Management, Trade & Distribution, Reimbursement, and Patient Services functions.
Kim joined Ipsen in 2014 and has held roles spanning value and access, marketing and sales. Most recently, she served as Vice President, Franchise Head, Neuroscience Business Unit, where she led the strategy and execution for all activities related to the company's neuroscience product portfolio in the United States. Before that, she served as Head of Oncology and Endocrinology Strategy and Operations and held a key role as part of the Value and Access Leadership Team, developing and implementing strategic objectives across the Ipsen US portfolio and largest customer channels, including payors, group purchasing organizations (GPOs), key hospital systems and federal accounts.
Kim is a passionate mentor and the Executive Sponsor for Elevate, Ipsen's first employee resource group, which is dedicated to advancing opportunities for women.
Before joining Ipsen, Kim led the market access account management teams for Cubist Pharmaceuticals and Optimer Pharmaceuticals. She began her career in the healthcare industry at Johnson & Johnson where she managed national accounts for LifeScan, a former division of J&J focused on diagnostic systems for patients living with diabetes.
Kim earned a BS from Rochester Institute of Technology. In 2018, she was named ‘Best Woman Sales Director' at the North America Women in Sales Awards and in 2020, was honored with a Luminary Award from the Healthcare Businesswomen's Association.
Job Titles:
- Member of the Compensation Committee
Job Titles:
- Vice President, Communications
- Vice President, Communications and Patient Advocacy
Liz Kalina is a Mom. She also is Vice President, Communications and Patient Advocacy for Ipsen North America. Liz leads external reputation, employee communications and engagement with advocacy and industry organizations.
With more than 20 years of experience in dynamic healthcare settings, Liz brings clarity to complex situations.
Before joining Ipsen, Liz led teams responsible for global internal and global portfolio and country communications for Alexion, with a focus on Western Europe, U.S., and Japan. At Shire, she held various communication and engagement roles in the areas of rare disease, immunology and hematology-from early pipeline to established portfolio. Earlier in her career Liz served in senior agency positions in the U.S. and Asia Pacific. She has led multi-year advocacy programs, corporate communications, change management and rapid response for blue-chip and start-up clients.
Liz is a graduate of Drury University.
Job Titles:
- Chairman of the Board of Directors
- Director
- Chairman of the Board of Directors ) Highrock S.Àr.L. 2 4, Represented by Anne BEAUFOUR
- Member of Innovation and Development Committee
Marc de Garidel joined Ipsen as Chairman and Chief Executive Officer in November 2010. He has been the Ipsen Chairman of the Board of Directors since July 2016.
Marc de Garidel is also Chief Executive Officer and Director of AZTherapies, Inc. since October 1st, 2020. He was previously, for 2 years and a half, Chief Executive Officer and Director of Corvidia Therapeutics, Inc. which was sold to Novo Nordisk in July 2020.
Marc de Garidel started his career with the group Eli Lilly and pursued at Amgen, from 1995 to 2010, with increasing responsibility positions in the US and Europe.
Marc de Garidel is Director of Claris Biotherapeutics since July 2020.
Previously, he was Director of several biotechnology companies, including Vice-Chairman of the Board of Directors of Vifor Pharma (Switzerland) between May 2017 and 2018 (formerly Galenica), of which he was member of the Board since 2015.
Marc de Garidel is a graduate from the French Engineering School ESTP and has an Executive MBA from Harvard Business School.
Job Titles:
- Chairman
- Member of Innovation and Development Committee
Mari Scheiffele joined Ipsen in November 2021 as EVP and President, Specialty Care International.
Mari brings 20 years of healthcare leadership experience, from across the pharmaceutical industry, having worked in the US, Europe and in Japan. She joined Ipsen from Novartis where she had held both global strategy and country operational roles in Japan and in the UK. Prior to joining Ipsen, Mari was the General Manager, Novartis Oncology UK & Ireland where with a focus on patient-centricity, evidence-based medicine, and partnership, she drove a successful business transformation.
In addition to her focus in oncology, Mari has worked in other specialty care environments such as ophthalmology, neuroscience, and immunology. Prior to Novartis, Mari was a partner at McKinsey & Company in New York and in Switzerland in pharmaceuticals and medical products.
Mari holds a doctorate in neuroscience from Harvard Medical School.
Job Titles:
- Member of Innovation and Development Committee
Job Titles:
- in 2019 As Senior Business Unit Director
- Vice President, Business Operations & Strategy and Chief of Staff
Mike brings strong leadership, a passion for developing others, strategic expertise and a 15-year track record of driving successful revenue, profit and business growth within the pharmaceutical industry and the last 3 years to Ipsen.
Prior to his current role, Mike joined Ipsen in 2019 as Senior Business Unit Director, Oncology. In this role, he was responsible for providing sales and marketing leadership in the commercialization of Ipsen Canada's oncology portfolio with a high performance, patient-focused and collaborative mindset. Mike developed and implemented strategies to grow a long-term oncology franchise, supported product launches and worked with members of the Ipsen Canada leadership team and North America and Global teams to create business opportunities within oncology.
Before joining Ipsen Canada, Mike held positions including Vice President of Commercial Operations at Paladin Labs, Head of Sales at Eisai Canada, and National Sales Director at GlaxoSmithKline.
Mike holds an Honours Kinesiology degree from the University of Western Ontario.
Job Titles:
- Senior Vice President, Head of Medical Affairs, North America
Monica de Abadal was appointed Senior Vice President, Head of Medical Affairs, North America in October 2021. As a key member of the North America Leadership Team and Chief Medical Officer Leadership Team, Monica is responsible for the strategic direction and leadership of our medical team as well as for planning, drug safety, and local medical affairs operations.
Monica has been with Ipsen since 2003 in several Medical Affairs roles with increasing responsibility. Most recently, she held the role of Vice President, Global Medical Excellence. Prior to that, she served as Vice President, Global Medical Affairs Services, Deputy CMO and Head of Publications. Monica has also served as the local Medical Director at Ipsen Australia. She is an experienced leader with a strong global background in transformation and leadership in Medical Affairs including Medical Strategy, Scientific Publications, Medical Communications, Medical Information, Clinical Operations, Medical Field excellence and Medical Governance. Monica currently serves as President of Europe and Middle East/Africa Region for the Medical Affairs Professional Society (MAPS).
Monica received her Medical Degree from Universitat Autònoma de Barcelona and a Master's in Healthcare Administration from the University of San Francisco.
Job Titles:
- Member of the Audit Committee
- Member of the Nomination Committee
- Member of Innovation and Development Committee
Job Titles:
- Chief Business Officer
- Executive Vice President
Philippe Lopes-Fernandes joined Ipsen in October 2020 as Executive Vice President, Chief Business Officer.
With more than 20 years of leadership and expertise in global business development and acquisitions within the pharmaceutical industry, Philippe is responsible for driving Ipsen's external innovation strategy and strengthening alliances across its key therapeutic areas of oncology, neuroscience and rare disease. He has an extensive track record of creating successful business development deals in multiple therapeutic areas in Europe, Asia and North America.
Prior to joining Ipsen, Philippe worked at Merck KGaA where he was the Senior Vice President, Global Head of Business Development and Alliance Management. Before that, he held a variety of roles at Merck KGaA in Business Development, Mergers & Acquisitions, Finance and Marketing in Germany, France, Portugal, Switzerland and the United States.
Philippe received his degree from the Institut Supérieur de Gestion (ISG) in Paris in 1994. He is a French External Trade advisor (Conseiller du Commerce Extérieur) and board member of several companies.
Job Titles:
- Member of the Compensation Committee
Job Titles:
- Chief Human Resources Officer
- Executive Vice President
Régis Mulot joined Ipsen in March 2018 as Executive Vice President, Chief Human Resources Officer.
Prior to joining Ipsen, Régis served as Executive Vice President, Chief Human Resources Officer at Staples Inc., the global specialty retail and e-commerce company and led a global team of over 600 professionals. Prior to his career with Staples (2009-18), Régis held HR leadership positions with Levi Strauss & Co (2002-08) and the technology start-up Broadnet Europe (2000-02), following earlier roles at GTECH Corporation (1994-2000), International Post Corporation (1991-94) and Chronopost SA (1989-91).
Régis served on the Board of Trustees, Simmons College (Boston, MA, USA); is Past Chairman of the Business Advisory Committee of the Simmons School of Management 2014-2017; Founder and former chair of the French-American HR Forum since 2016-2018. He has been co-chair of the Boston CHRO (Chief Human Resources Officers) Leadership summit between 2014 and 2018 and is a Gartner CHRO Leadership Board member since 2017.
Régis holds a DESS Entreprises Publiques (Master in Public Administration) from Paris XI-Sud in partnership with Paris IX-Dauphine and Institut International d'Administration Publique (IIAP). He also holds a Maîtrise Droit Public (Bachelor of Law) from Paris II-Panthéon-Assas and is a Beta Gamma Sigma honoree from the Simmons College Chapter.
Job Titles:
- Vice President, Head of New Products & Innovation
Job Titles:
- Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs, Patients Safety and Patients Affairs
Steven Hildemann, M.D., Ph.D. joined Ipsen in March 2020 as Chief Medical Officer.
Prior to joining Ipsen, Steven held leadership roles in science-based bioethics and built an innovative digital health startup in cancer care after serving for five years as Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs and Global Patient Safety at Merck. He also held several strategic leadership positions with biopharmaceutical companies such as Pharmacia-Pfizer and Schering-Plough-MSD.
Steven is board certified in internal medicine and cardiology with broad clinical training across internal medicine including medical oncology, gastroenterology, rheumatology and pulmonary oncology at university hospitals in Munich, Germany. Throughout his career, he has engaged in part-time clinical practice, late-stage pharmaceutical research and medical teaching. Steven received his M.D., Ph.D. at the Albert Ludwig University of Freiburg, Germany, where he continues to serve as an adjunct Professor of Medicine.
Job Titles:
- Executive Vice President
- President, North America
- Executive Vice President, President of North America
- Senior Vice President and Franchise Head of Oncology
Stewart Campbell was appointed Executive Vice President and President of North America in November 2021.
Stewart joined Ipsen as Senior Vice President and Franchise Head of Oncology in May 2021 from Roche/Genentech where he spent more than 14 years, responsible for the lifecycle management of some of Roche's oncology blockbusters, including both commercial and clinical development globally. Through a career of more than 20 years in the pharmaceutical industry, Stewart has deep experience leading country and global commercial functions in oncology and specialty care markets, including Canada, Switzerland, and the United States.
Stewart is a graduate of Concordia University in Montreal, Canada, where he received his B.S. in physiology with a minor in physics. He received his MBA in corporate finance from Queens University in Kingston, Canada and an additional MBA in business strategy from the Johnson School of Management at Cornell University in Ithaca, New York.